Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

PDZ-Binding Kinase/T-LAK Cell-Originated Protein Kinase, a Putative Cancer/Testis Antigen with an Oncogenic Activity in Breast Cancer

15 Sept 2006

Abstract excerpt

Breast cancer is one of the most common cancers among women. To discover molecular targets that are applicable for development of novel breast cancer therapy, we previously did genome-wide expression profile analysis of 81 breast cancers and found dozens of genes that were highly and commonly up-regulated in breast cancer cells. Among them, we here focused on one gene that encodes PDZ-binding kinase/T-LAK...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Cancer Mechanisms and Therapy
Share to FOXO transcription factor regulation
Share to Signaling Pathways in Disease

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 16982762
DOI: 10.1158/0008-5472.can-06-1601

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-08.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

PDZ-Binding Kinase/T-LAK Cell-Originated Protein Kinase, a Putative Cancer/Testis Antigen with an Oncogenic Activity in Breast CancerPMID 16982762Read ↗

Prognostic Value of PDZ-Binding Kinase/T-LAK Cell-Originated Protein Kinase (PBK/TOPK) in Patients with CancerSemantic proximity Read ↗

Protein expression of PDZ-binding kinase is up-regulated in hematologic malignancies and strongly down-regulated during terminal differentiation of HL-60 leukemic cells.Semantic proximity Read ↗

High expression of PDZ-binding kinase is correlated with poor prognosis and immune infiltrates in hepatocellular carcinomaSemantic proximity Read ↗

High Expression of PDZ-binding Kinase Is Correlated With Poor Prognosis and Immune Infiltrates in Hepatocellular CacinomaSemantic proximity Read ↗

PBK is a potential therapeutic target and prognostic biomarker in ovarian cancer: integrating bioinformatics and clinical analysisSemantic proximity Read ↗

Comprehensive analysis of PLKs expression and prognosis in breast cancer.Semantic proximity Read ↗

STAT4 facilitates PD‐L1 level via IL‐12R/JAK2/STAT3 axis and predicts immunotherapy response in breast cancerSemantic proximity Read ↗

Diverse functions of Tribbles homolog 3 in cancers and its potential as a therapeutic targetSemantic proximity Read ↗

PDZ binding kinase, regulated by FoxM1, enhances malignant phenotype via activation of β-Catenin signaling in hepatocellular carcinoma.Semantic proximity Read ↗

Strategic Developments & Future Perspective on Gene Therapy for Breast Cancer: Role of mTOR and Brk/ PTK6 as Molecular TargetsSemantic proximity Read ↗

Critical roles of LGN/GPSM2 phosphorylation by PBK/TOPK in cell division of breast cancer cells.Semantic proximity Read ↗

MAP4K4: an emerging therapeutic target in cancerSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.